The longevity peptide that rewards skepticism.
A compounded Epithalon prescription for the well-read patient who wants the molecule, evidence gaps, and sourcing stated plainly.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
About 10 minutes. No charge unless your clinician approves.
Small molecule. Serious questions.
Epithalon tends to find people after they have already gone deep. Cellular aging, telomeres, pineal peptides, short-peptide signaling. By the time the name appears on your screen, you have usually read enough to know that longevity claims can outrun the evidence fast.
What makes Epithalon compelling is how defined it is.
The molecule is a four-amino-acid sequence, Ala-Glu-Asp-Gly, also written AEDG, designed from the amino acid composition of a pineal peptide extract.1 Researchers have used that specific sequence in cell, animal, and human work examining short-peptide signaling and gene regulation. It is not a broad hormone signal or an undefined extract. It is one deliberately defined tetrapeptide with a research history that can be examined claim by claim.
That distinction matters in a longevity conversation. The interesting part is not pretending a four-amino-acid peptide has solved aging. It is that the molecule is specific enough to ask precise biological questions about it, and the existing research is specific enough to make those questions worth reading closely.
Skepticism belongs in the conversation. The molecule is defined, licensed sourcing and clinician oversight are explicit, and the human evidence gap remains part of the decision.
- Araj SK, et al. Overview of Epitalon, Highly Bioactive Pineal Tetrapeptide with… Int J Mol Sci. 2025.PubMed
For people who want the interesting science without the mythology.
The Footnote Reader
You already know the headline claims. What you want now is the version that separates the molecule, the research, and the marketing story instead of blending them together.
The Longevity System Builder
Sleep, training, hormones, and the fundamentals are already being handled. You are evaluating what deserves to sit beyond the basics, not looking for a shortcut around them.
The Skeptic Who Is Still Interested
You can be intrigued by a molecule and unconvinced by the marketing around it at the same time. In this category, that is often the most useful place to start.
FDA and the July 2026 PCAC materials use the name Epitalon for the same AEDG tetrapeptide sold here as Epithalon. PCAC recommended Epitalon for the 503A Bulks List by a 7-5-1 vote, but that recommendation is advisory and FDA has not acted. The preparation offered here is compounded and is not an FDA-approved drug product. A licensed provider determines candidacy from your full Assessment.
This might not be the right fit if:
- You have active or recent cancer without oncology clearance.
- You are pregnant or breastfeeding.
- You have a known hypersensitivity to any component of the preparation.
- You are under 18.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Epithalon, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- An independent licensed provider reviews your full Assessment and gives you a real answer either way.
- If approved, your dose and duration are set for you rather than left to guesswork.
- Your prescription is compounded by a licensed US pharmacy, with follow-up built into your care.
- Provider review, the prescription if approved, pharmacy, and shipping handled inside one plan.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
More in Longevity.
BPC-157
The peptide everyone asks about, inside real medicine.
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
MOTS-c
A mitochondrial signal, not a stimulant.
A compounded mitochondrial-derived signaling peptide studied in cellular stress-response and AMPK-related metabolic biology.
Glutathione
Antioxidant defense, under clinical direction.
Compounded injectable glutathione for clinician-guided antioxidant defense beyond the supplement aisle.
Serious risks
- Human safety data for Epithalon are limited, especially for the compounded injectable use offered here
- The long-term effects of repeated exposure are not well characterized
- Pregnancy and breastfeeding safety are not established
Because it is injectable
- Injection-site reactions are possible with any injected preparation
Laboratory work has examined Epitalon effects on telomerase and telomere biology, including a 2025 study that reported telomere-length changes in both normal and breast-cancer cell lines.2 That does not show that Epithalon causes or treats cancer, but it makes active or recent malignancy an important part of provider review. Your provider weighs these uncertainties against your history before prescribing.
- Al-Dulaimi S, et al. Epitalon increases telomere length in human cell lines through… Biogerontology. 2025.PubMed
Asked and answered.
You are not charged, and you are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
Epitalon has been studied for more than two decades across cell, animal, and some human research. A 2025 review cataloged work spanning gene regulation, pineal biology, telomerase, and other pathways while also identifying important gaps in structural and mechanistic evidence.1 There is no randomized clinical evidence establishing a longevity outcome in humans.
Epitalon, the same tetrapeptide sold here as Epithalon, received a favorable 7-5-1 recommendation from the Pharmacy Compounding Advisory Committee in July 2026 for possible inclusion on the 503A Bulks List. That recommendation is advisory, and FDA has not issued a final rule adding it to the list. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
Yes. That association comes from laboratory research, not from a proven human longevity outcome. Older work reported telomerase activity in cultured human cells, and a 2025 study reported telomere-length changes in several cell lines after Epitalon exposure.2 Cell-culture findings do not establish that a compounded Epithalon treatment lengthens human telomeres, slows aging, or extends lifespan. Those are different claims and require different evidence.
Because uncertainty and irrelevance are not the same thing. Epithalon is a defined molecule with a real research record and unanswered questions that some informed patients want evaluated medically. The value of clinician-guided care is being able to explore that interest without pretending the unanswered parts are settled.
The most important difference is not access to the molecule. It is what surrounds it. Here, a licensed provider reviews whether Epithalon belongs in your care and a licensed US pharmacy compounds it to your individual prescription. The FDA has found products sold as research chemicals under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. As a research-literate patient, you should demand more from an emerging treatment, not less. AnthologyRX+ gives the molecule a prescriber, a pharmacy of record, and a medical context strong enough to hold both the interesting evidence and its limits.
- Araj SK, et al. Overview of Epitalon, Highly Bioactive Pineal Tetrapeptide with… Int J Mol Sci. 2025.PubMed
- Al-Dulaimi S, et al. Epitalon increases telomere length in human cell lines through… Biogerontology. 2025.PubMed
- FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, and FDA Warning Letter to Gram Peptides, March 31, 2026.